Dynavax Technologies reported $128K in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adma Biologics ADMA:US USD 20K 0
Agenus AGEN:US USD 3.06M 107K
AstraZeneca AZN:LN USD 387M 0
Astrazeneca AZN:US USD 387M 0
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Chimerix CMRX:US USD 88K 0
Dynavax Technologies DVAX:US USD 128K 1000
Glaxosmithkline GSK:US GBP 1.35B 0
Idera Pharmaceuticals IDRA:US USD 59K 6K
Minerva Neurosciences NERV:US USD 1000 0
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 890M 0
Roche Holding ROG:VX 107M 0
Sarepta Therapeutics SRPT:US USD 9K 0
Tg Therapeutics TGTX:US USD 146K 1000